Author

Anne M. Macy

Phoenix VA Health Care SystemORCID 0000-0003-4508-3658Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Karen Taraszka HastingsiD· 2 shared Aaron R. MangoldiD· 1 shared Allison Jeanne RemingtoniD· 1 shared Allison SchwartziD· 1 shared Alysia HughesiD· 1 shared Anngela C. AdamsiD· 1 shared Ata S. MoshiriiD· 1 shared Blair L. DeBuysscheriD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Karen Taraszka HastingsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedOct 1, 2025

Distinct sets of molecular characteristics define tumor-rejecting neoantigens

Anngela C. Adams, Anne M. Macy, Elizabeth S. Borden…·Karen Taraszka Hastings

The paper identifies molecular features of tumor-rejecting neoantigens in cSCC and shows how they differ from non-immunogenic neoantigens.

5 citations

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 22, 2025

B cell responses specific for polyomavirus-derived oncoprotein are predictive of Merkel cell carcinoma tumor control

Haroldo J. Rodriguez, Allison Jeanne Remington, Matthew D. Gray…·Justin J. Taylor

The paper shows that B cells specific for viral oncoproteins in Merkel cell carcinoma tumors predict long-term disease control and enhance T cell responses.

DOI 10.1101/2025.07.22.666002

humanproteomics

𝕏 PostBluesky

Cancer BiologyPLoS ONEPeer-reviewedJul 5, 2024

Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer

Emily Tsutsumi, Anne M. Macy, Janine R. Lobello…·Suwon Kim

This study investigates the immune microenvironment of ING4-deficient breast cancer, showing a suppressive immune environment linked to poor patient survival.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky